Gynae: Ovarian Disorders Flashcards
What is PCOS?
Polycystic ovarian syndrome
Condition in which there are metabolic & reproductive problems in women. Characteristic features: multiple ovarian cysts, infertility, oligomenorrhoea, hyperandrogenism & insulin resistance
When does PCOS tend to present (age wise)?
Puberty
State some risk factors for PCOS
- FH
- Diabetes
- Obesity
- Irregular menstruation
Describe the pathophysiology of PCOS
Insulin resistance is a crucial part of PCOS. When someone is resistant to insulin, their pancreas has to produce more insulin to get a response from the cells of the body. Insulin promotes the release of androgens from the ovaries and adrenal glands. Therefore, higher levels of insulin result in higher levels of androgens (such as testosterone). Insulin also suppresses sex hormone-binding globulin (SHBG) production by the liver. SHBG normally binds to androgens and suppresses their function. Reduced SHBG further promotes hyperandrogenism in women with PCOS.
The high insulin levels contribute to halting the development of the follicles in the ovaries, leading to anovulation and multiple partially developed follicles (seen as polycystic ovaries on the scan).
Describe typical presentation of PCOS
- Oligomenorrhoea or amenorrhoea
- Infertility
- Obesity (~70%)
- Hirsutism
- Acne
- Male pattern hair loss
State some differential diagnoses for hirsutism
- Medications (corticosteroids, testosterone, anabolic steroids, phenytoin, ciclosporin)
- Cushing’s syndrome
- Congenital adrenal hyperplasia
- Ovarian or adrenal tumours secreting androgens
Alongside features listed in typical presentation FC, what other problems may women with PCOS experience?
- Insulin resistance and diabetes
- Acanthosis nigricans
- Cardiovascular disease
- Hypercholesterolaemia
- Endometrial hyperplasia and cancer
- Obstructive sleep apnoea
- Depression and anxiety
- Sexual problems
What investigations are done in women with suspected PCOS?
Bedside
- Oral glucose tolerance test
Blood tests
- Testosterone
- SHBG
- LH
- FSH
- TSH
- Prolactin
- Progesterone??? CHECK
Imaging
- Transvaginal pelvic ultrasound (NOTE: not reliable in adolescents for diagnosis of PCOS)
What blood results would suggest PCOS?
- Raised LH
- Raised LH:FSH ratio
- Raised testosterone
- SHBG: low
- Testosterone: normal or mildly elevated
- Progesterone: low throughout menstrual cycle
- Prolactin: may be mildly raised
When is it best to measure LH & FSH?
Days 1-3 of menstrual bleed
What findings on ultrasound would suggest PCOS?
“String of pearls appearance”
- 12 or more developing follicles in one ovary
- Or ovarian volume more than 10cm3
Remind yourself of the findings in OGTT that would indicate diabetes
An OGTT is performed in the morning prior to having breakfast. It involves taking a baseline fasting plasma glucose, giving a 75g glucose drink and then measuring plasma glucose 2 hours later. It tests the ability of the body to cope with a carbohydrate meal. The results are:
- Impaired glucose tolerance – plasma glucose at 2 hours of 7.8 – 11.1 mmol/l
- Diabetes – plasma glucose at 2 hours above 11.1 mmol/l
What criteria used to diagnose PCOS? Describe this criteria
Rotterdam Criteria
At least 2 of the three features:
- Oligoovulation or anovulation (presenting with irregular or absent periods)
- Hyperandrogenism (characterised by hirsutism & acne)
- Polycystic ovaries on ultrasound (or ovarian volume >10cm3)
Management of PCOS can be split into 5 categories; state these
- General management
- Managing hirsutism
- Managing acne
- Managing infertility
- Managing risk endometrial cancer/oligomenorrhoea or amenorrhoea
Discuss the general management of PCOS
Must reduce risk associated with obesity, T2DM, hypercholesterolaemia, CVD:
- Weight loss
- Exercise
- Smoking cessation
- Antihypertensives
- Statins (QRISK >10%)
- Orlistat (lipase inhibitor to help weight loss in women with BMI >30)
- Assess for & treat any other complications:
- Endometrial hyperplasia
- Depression & anxiety
- OSA
Discuss the management of hirsutism in PCOS
- Weight loss can improve symptoms
- Hair removal (waxing, shaving, plucking)- many women already tried
- Co-cyprindiol (Dianette): COCP licensed for treatment of hirsutism & acne as has anti-androgen effect
- Topical eflornithine for facial hirsutism (takes 6-8 weeks to work and hirsutism often return when stop using)
-
Other medications that have anti-androgen effects:
- Spironolactone (mineralocorticoid receptor antagonist)
- Finasteride (5-alpha reductase inhibitor)
- Flutamide (non-steroidal anti-androgen)
Discuss the management of acne in PCOS
- COCP Co-cyprindiol (Dianette) is first line
- Other acne management:
- Topical benzoyl peroxide
- Topical macrolide antibiotics
- Topical azelaic acid
- Oral tetracycline abx
- Isotretinoin
State one ADR of Co-cyprindiol (Dianette)
Significantly increased risk of VTE hence often stopped after 3 months
Discuss the management of subfertility in PCOS
- Weight loss
- Metformin (+/- clomifene) *NICE recommend metformin for women with BMI >25
- Clomifene
- Ovarian drilling (laparoscopic surgery in which put multiple holes in ovaries using diathermy or laser)
Discuss the management of risk of endometrial cancer/oligomenorrhea/amenorrhoea in PCOS
In Oligoovulation or anovulation, there is unopposed oestrogen hence can lead to endometrial hyperplasia which has risk of becoming malignant.
- Options to induce withdrawal bleed (at least 3 times per year):
- COCP
- Cyclical progesterone (E.g. medroxyprogesterone acetate 10mg once a day for 14 days)
- Mirena coil for continuous protection
Explain why women with PCOS at risk of endometrial cancer
Under normal circumstances, the corpus luteum releases progesterone after ovulation. Women with PCOS do not ovulate (or ovulate infrequently), and therefore do not produce sufficient progesterone. They continue to produce oestrogen and do not experience regular menstruation. Consequently, the endometrial lining continues to proliferate under the influence of oestrogen, without regular shedding during menstruation. This is similar to giving unopposed oestrogen in women on hormone replacement therapy. It results in endometrial hyperplasia and a significant risk of endometrial cancer.
How should we investigate women with extended gaps (>3 months) between periods or abnormal bleeding?
- Pelvic ultrasound to assess endometrial thickness
- Give cyclical progestogens to induce period prior to ultrasound and if thickness is >10mm need to refer for biopsy to exclude endometrial hyperplasia or cancer